These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17280660)
41. Coxsackievirus B3 infection and PBDE exposure causes organ-specific effects on CYP-gene expression in the mouse. Lundgren M; Darnerud PO; Molin Y; Lilienthal H; Blomberg J; Ilbäck NG Toxicology; 2007 Dec; 242(1-3):91-9. PubMed ID: 17964053 [TBL] [Abstract][Full Text] [Related]
42. Docosahexaenoic acid downregulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes via the c-Jun NH2-terminal kinase mitogen-activated protein kinase pathway. Lu CY; Li CC; Liu KL; Lii CK; Chen HW Mol Nutr Food Res; 2009 Mar; 53(3):341-8. PubMed ID: 18803253 [TBL] [Abstract][Full Text] [Related]
43. In vitro assays for induction of drug metabolism. Lake BG; Price RJ; Giddings AM; Walters DG Methods Mol Biol; 2009; 481():47-58. PubMed ID: 19096794 [TBL] [Abstract][Full Text] [Related]
44. Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. Saarikoski ST; Wikman HA; Smith G; Wolff CH; Husgafvel-Pursiainen K J Histochem Cytochem; 2005 May; 53(5):549-56. PubMed ID: 15872048 [TBL] [Abstract][Full Text] [Related]
45. Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells. Zordoky BN; El-Kadi AO Vascul Pharmacol; 2008; 49(4-6):166-72. PubMed ID: 18707023 [TBL] [Abstract][Full Text] [Related]
46. Cytochrome P450-mediated metabolism in the human gut wall. Thelen K; Dressman JB J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992 [TBL] [Abstract][Full Text] [Related]
47. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats. Parkin DR; Lu Y; Bliss RL; Malejka-Giganti D Food Chem Toxicol; 2008 Jul; 46(7):2451-8. PubMed ID: 18486294 [TBL] [Abstract][Full Text] [Related]
48. Examination of Zolpidem effects on AhR- and PXR-dependent expression of drug-metabolizing cytochromes P450 in primary cultures of human hepatocytes. Bachleda P; Vrzal R; Pivnicka J; Cvek B; Dvorak Z Toxicol Lett; 2009 Dec; 191(1):74-8. PubMed ID: 19686824 [TBL] [Abstract][Full Text] [Related]
49. Modulation of CYP1A1 and CYP2B1 expression upon cell cycle progression in cultures of primary rat hepatocytes. Henkens T; Vinken M; Vanhaecke T; Rogiers V Toxicol In Vitro; 2007 Oct; 21(7):1253-7. PubMed ID: 17560764 [TBL] [Abstract][Full Text] [Related]
50. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics. Elrick LJ; Leel V; Blaylock MG; Duncan L; Drever MR; Strachan G; Charlton KA; Koruth M; Porter AJ; Wright MC J Hepatol; 2005 Jun; 42(6):888-96. PubMed ID: 15885360 [TBL] [Abstract][Full Text] [Related]
51. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Smith G; Wolf CR; Deeni YY; Dawe RS; Evans AT; Comrie MM; Ferguson J; Ibbotson SH Lancet; 2003 Apr; 361(9366):1336-43. PubMed ID: 12711469 [TBL] [Abstract][Full Text] [Related]
52. Constitutive expression and activity of cytochrome P450 in conventional pigs. Nielsen SD; Bauhaus Y; Zamaratskaia G; Junqueira MA; Blaabjerg K; Petrat-Melin B; Young JF; Rasmussen MK Res Vet Sci; 2017 Apr; 111():75-80. PubMed ID: 28063306 [TBL] [Abstract][Full Text] [Related]
53. Cell type-specific expression and localization of cytochrome P450 isoforms in tridimensional aggregating rat brain cell cultures. Vichi S; Sandström von Tobel J; Gemma S; Stanzel S; Kopp-Schneider A; Monnet-Tschudi F; Testai E; Zurich MG Toxicol In Vitro; 2015 Dec; 30(1 Pt A):176-84. PubMed ID: 25795400 [TBL] [Abstract][Full Text] [Related]
54. Characterization and expression of extrahepatic CYP2S1. Deb S; Bandiera SM Expert Opin Drug Metab Toxicol; 2009 Apr; 5(4):367-80. PubMed ID: 19368491 [TBL] [Abstract][Full Text] [Related]
55. Modulation of cytochrome P450 gene expression in primary hepatocytes on various artificial extracellular matrices. Adachi T; Goto M; Cho CS; Akaike T Biochem Biophys Res Commun; 2011 Oct; 413(4):577-81. PubMed ID: 21930114 [TBL] [Abstract][Full Text] [Related]
56. A transcriptomic approach to elucidate the physiological significance of human cytochrome P450 2S1 in bronchial epithelial cells. Madanayake TW; Lindquist IE; Devitt NP; Mudge J; Rowland AM BMC Genomics; 2013 Nov; 14():833. PubMed ID: 24279958 [TBL] [Abstract][Full Text] [Related]
57. Maintenance of High Cytochrome P450 Expression in HepaRG Cell Spheroids in DMSO-Free Medium. Aleksandrova AV; Burmistrova OA; Fomicheva KA; Sakharov DA Bull Exp Biol Med; 2016 May; 161(1):120-4. PubMed ID: 27265124 [TBL] [Abstract][Full Text] [Related]
58. A Review on the Expression and Metabolic Features of Orphan Human Cytochrome P450 2S1 (CYP2S1). Yan P; Eng OC; Yu CJ Curr Drug Metab; 2018; 19(11):917-929. PubMed ID: 29804525 [TBL] [Abstract][Full Text] [Related]
59. Down-regulated expression of cytochrome P450 (CYP) involved in the development and progression of esophageal adenocarcinoma. Wang XW; Xu M; Wang WQ; Wang HB; Sun YG; Zhou G; Gao HJ; Fang DC Hepatogastroenterology; 2009; 56(94-95):1371-6. PubMed ID: 19950794 [TBL] [Abstract][Full Text] [Related]
60. Metabolic characterization of cell systems used in in vitro toxicology testing: lung cell system BEAS-2B as a working example. Garcia-Canton C; Minet E; Anadon A; Meredith C Toxicol In Vitro; 2013 Sep; 27(6):1719-27. PubMed ID: 23669205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]